Price loading...

The 2023-2028 Outlook for Therapeutics for Narcolepsy with Cataplexy in the United States

Price data last checked 103 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
11 November 2022

Similar Products You Might Like

The 2023-2028 World Outlook for Therapeutics for Narcolepsy with Cataplexy
99% match

The 2023-2028 World Outlook for Therapeutics for Narcolepsy with Cataplexy

£795.00 13 Jan 2026
The 2023-2028 Outlook for Narcolepsy Drugs in the United States
98% match

The 2023-2028 Outlook for Narcolepsy Drugs in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
97% match

The 2023-2028 Outlook for Insomnia Therapeutics in the United States

£520.00 15 Jan 2026
The 2023-2028 World Outlook for Narcolepsy Therapeutics
97% match

The 2023-2028 World Outlook for Narcolepsy Therapeutics

Out of Stock 08 Jan 2026
The 2023-2028 Outlook for Narcolepsy Drugs in India
97% match

The 2023-2028 Outlook for Narcolepsy Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Insomnia Drugs in the United States
96% match

The 2023-2028 Outlook for Insomnia Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Nocturia Drugs in the United States
96% match

The 2023-2028 Outlook for Nocturia Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 World Outlook for Insomnia Therapeutics
96% match

The 2023-2028 World Outlook for Insomnia Therapeutics

£795.00 11 Jan 2026
The 2023-2028 Outlook for Insomnia in the United States
96% match

The 2023-2028 Outlook for Insomnia in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Prescription Sleep-Aid Insomnia Drugs in the United States
96% match

The 2023-2028 Outlook for Prescription Sleep-Aid Insomnia Drugs in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Therapeutic Plasma Exchange for Neurological Disorders in the United States
96% match

The 2023-2028 Outlook for Therapeutic Plasma Exchange for Neurological Disorders in the United States

£520.00 09 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Anti-Snoring Treatments in the United States
96% match

The 2023-2028 Outlook for Anti-Snoring Treatments in the United States

£520.00 10 Feb 2026
The 2023-2028 Outlook for Sleep Aids in the United States
96% match

The 2023-2028 Outlook for Sleep Aids in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Sleep Apnea Treatment Devices in the United States
96% match

The 2023-2028 Outlook for Sleep Apnea Treatment Devices in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Neurostimulation Devices in the United States
96% match

The 2023-2028 Outlook for Neurostimulation Devices in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Motion Sickness Medications in the United States
96% match

The 2023-2028 Outlook for Motion Sickness Medications in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in the United States
96% match

The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in the United States

£520.00 14 Jan 2026